Lidocain Deltamedica

Lidocaine Hydrochloride, the active ingredient in Lidocain Deltamedica, is a local anesthetic presented as a sterile solution for epidural, infiltration, intravenous and subcutaneous use. It provides reversible nerve block to facilitate minor surgical and diagnostic procedures. GNH USA supplies Lidocain Deltamedica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine Hydrochloride is employed to achieve local anesthesia across several clinical pathways. - Minor surgical procedures: provides localized numbness to enable surgery without general anesthesia. - Epidural analgesia: delivers pain relief during labor or postoperative periods. - Intravenous regional anesthesia (Bier block): produces temporary limb anesthesia for short procedures.

Lidocaine Hydrochloride may cause a range of adverse reactions.

Common Side Effects: - Transient burning or tingling at the injection site. - Mild dizziness or light‑headedness. - Nausea or mild gastrointestinal upset. - Temporary hypotension, especially with large doses. - Metallic taste in the mouth.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with rash, swelling, or airway compromise. - Cardiac arrhythmias, including ventricular tachycardia. - Central nervous system toxicity such as seizures or loss of consciousness. - Methemoglobinemia leading to cyanosis and reduced oxygen delivery.

When using Lidocain Deltamedica, clinicians should observe several safety measures. - Assess patient allergy history: confirm no known lidocaine hypersensitivity. - Monitor cardiovascular status: watch for hypotension or bradycardia during administration. - Use the lowest effective dose: limit systemic exposure to reduce toxicity risk. - Avoid use in severe hepatic impairment: adjust dosing or consider alternatives. - Pregnancy and breastfeeding: use only if the benefit outweighs potential risk. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lidocaine may interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): can cause severe cardiotoxicity. - Beta‑blockers (e.g., propranolol): combined use may increase bradycardia and hypotension. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise plasma lidocaine concentrations.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase bleeding tendency when used with regional techniques. - General anesthetics (e.g., propofol): additive central nervous system depression. - Loop diuretics (e.g., furosemide): may enhance lidocaine toxicity by reducing plasma protein binding.